Literature DB >> 26278702

Clinical implications of intratumoral heterogeneity of HER2 gene amplification in locally advanced HER2-positive breast cancer patients.

Bekir Hacioglu1, Serkan Akin1, Ali R Sever2, Kadri Altundag1.   

Abstract

Entities:  

Keywords:  HER2-positive; adjuvant; breast cancer; chemotherapy; complete remission; intratumoral heterogeneity; locally advanced; neoadjuvant; receptors; trastuzumab

Mesh:

Substances:

Year:  2015        PMID: 26278702     DOI: 10.2217/fon.15.164

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  1 in total

1.  Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics.

Authors:  Allen Li; Jamie M Keck; Swapnil Parmar; Janice Patterson; Marilyne Labrie; Allison L Creason; Brett E Johnson; Molly Downey; George Thomas; Carol Beadling; Laura M Heiser; Annette Kolodzie; Alexander R Guimaraes; Christopher L Corless; Joe W Gray; Gordon B Mills; Raymond C Bergan; Zahi I Mitri
Journal:  NPJ Precis Oncol       Date:  2021-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.